Faes Farma, S.A. (BME:FAE)

Market Cap	1.31B
Revenue (ttm)	543.77M
Net Income (ttm)	105.34M
Shares Out	311.26M
EPS (ttm)	0.34
PE Ratio	12.52
Forward PE	13.72
Dividend	0.16 (3.72%)
Ex-Dividend Date	Jul 3, 2025

Volume	30,893
Average Volume	93,363
Open	4.230
Previous Close	4.220
Day's Range	4.185 - 4.230
52-Week Range	3.270 - 4.730
Beta	0.35
RSI	43.71
Earnings Date	Oct 27, 2025

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1933
• Employees: 1,775
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: FAE

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.